News | January 04, 2023
Themis Medicare launches Lenzetto for treatment of menopausal symptoms
It ensures sufficient serum estradiol levels to alleviate menopausal symptoms
It ensures sufficient serum estradiol levels to alleviate menopausal symptoms
Kyfora Bio will focus on the synthesis of cationic polymers, lipids, and other materials used in nucleic acid delivery for cell and gene therapies.
This ambitious anti-TB campaign, as part of IOCL’s CSR, aims to ensure early identification of presumptive TB and prompt diagnosis using high-sensitivity diagnostic tests at the doorstep
Advent will also be making an open offer to acquire additional 26% of the outstanding equity shares of the company from the public shareholders.
China is now focusing on establishing volume and enhancing capabilities for innovative high value drug production
Desonide Cream, 0.05%, has an estimated market size of US $12 million for twelve months ending Sep 2022 according to IQVIA
Asia’s premier and USA-patented, ANSSI Wellness for spinal decompression was launched in Pune
Diclofenac Sodium Topical Solution USP, 2% w/w has an estimated market size of US $512 million for twelve months ending Sep 2022 according to IQVIA
The inspection of the facility resulted in issuance of a Form-483 with eight observations each for the Drug Product facility and API facility at the site
Nifedipine Extended-Release Tablets have an estimated market size of US $56 million for twelve months ending September 2022
Subscribe To Our Newsletter & Stay Updated
